A one-minute look at managed care news during the week of April 13, 2015, including a the official repeal of the sustainable growth rate formula and a look at the rising cost of generic drugs.
Weeks after the House passed legislation that would repeal the sustainable growth rate (SGR) formula that determines Medicare payments, the Senate overwhelmingly passed the legislation as well. Two days later President Barack Obama signed the bill into law.
The Office of the Inspector General of HHS will review the impact of generic drug price increases on the Medicaid drug rebate program. Last year, The American Journal of Managed Care (AJMC)'s co-editor-in-chief, A. Mark Fendrick, MD, wrote about the costs of non-preferred generic drug pricing tiers.
Finally, there's still time to join AJMC in San Diego, April 30-May 1, for the third annual ACO and Emerging Healthcare Delivery Coalition. Learn more and register here.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More